|

Midazolam Clinical Trials

14 actively recruiting trials across 8 locations

▲ +1 trial since August 2026

Also known as: Dormicum, Hypnovel, Randomized Controlled Phase Intervention 2, Seizalam

Pipeline

Phase 1: 5Phase 3: 4Phase 4: 1Phase 1/2: 1

Top Sponsors

  • Pfizer2
  • Yangzhou University1
  • University Hospital, Montpellier1
  • Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital1
  • Nuvalent Inc.1

Indications

Other5 trials

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
Phase 1
Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia
Phase 3
Intranasal Dexmedetomidine vs Oral Midazolam for Premedication in Pediatric Surgery
N/A
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
N/A
Remimazolam for Postoperative Atrial Fibrillation
N/A

Birmingham, Alabama2 trials

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

University of Alabama at Birmingham

Phase 3
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

University of Alabama at Birmingham

Phase 3

Tucson, Arizona1 trial

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

University of Arizona - Cancer Center

Phase 1

Greenbrae, California1 trial

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

Marin Cancer Care Inc

Phase 3

Orange, California1 trial

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

University of California Irvine Medical Center

Phase 1/2

New Haven, Connecticut1 trial

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Pfizer Clinical Research Unit - New Haven

Phase 1

Coral Gables, Florida1 trial

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center

Phase 1

Orlando, Florida1 trial

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site

Phase 1

Glenview, Illinois1 trial

Patient Quality of Recovery After TAVR With Different Sedation Regimens

Endeavor Health

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.